Max Robotics — Global Service Robot Directory + US Certification

About

Mingmin Li is a pioneering urologic surgeon whose research has significantly advanced the field of minimally invasive kidney surgery, particularly through the adoption and validation of robotic-assisted techniques. His major contributions center on comparative effectiveness studies that systematically evaluate robotic partial nephrectomy (RPN) against traditional open and laparoscopic approaches. Through rigorous meta-analyses and propensity-score matched analyses, Li has provided critical evidence demonstrating that RPN offers comparable oncologic outcomes with reduced perioperative morbidity, including lower blood loss and shorter hospital stays. His landmark 2014 systematic review and meta-analysis, which has garnered 148 citations, remains a foundational reference in the field. Li’s work also explores the correlation between tumor anatomical complexity scores (such as RENAL and centrality index) and warm ischemia time, helping surgeons better predict operative challenges. Notably, he performed the first clinical case in China of robotic-assisted laparoscopic nephrectomy combined with inferior vena caval thrombectomy for level II tumor thrombus, showcasing his technical innovation. With over 230 total citations across his most-cited works, Li’s research has shaped global surgical practice, offering robust evidence for the safety and efficacy of robotic partial nephrectomy in treating kidney tumors.